Officials of regulatory body Central Drugs Standard Control Organization (CDSCO) will visit drug manufacturing units in India over the next three to four years to train the producers in good manufacturing practices, CDSCO chief GN Singh said. This comes in the wake of many batches of Indian drugs being rejected by the US Food and Drug Administration, he added. 